Response by Singfer and Defreyne to Letter Regarding Article, "Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients". Issue 3 (March 2018)